FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
Today's Liberal News
By Katherine Ellen Foley
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
FDA approves first over-the-counter Narcan
Narcan can now be sold in gas stations, convenience stores and grocery stores.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
CDC adds Covid-19 vaccinations to immunization schedules for children, adults
The guidance formalizes current recommendations, and does not mandate vaccines.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Company executives said they estimated 2023 would be a transition year as the company pivots to a commercial market instead of a government market.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.
Second Alzheimer’s treatment showing modest benefits for patients approved by FDA
The agency granted accelerated approval to Leqembi on Friday.
Second Alzheimer’s treatment showing modest benefits for patients approved by FDA
The agency granted accelerated approval to Leqembi on Friday.